Advancement in stationary phase for peptide separation helps in protein identification: Application to atheroma plaque proteomics using nano-chip liquid chromatography and mass spectrometry

Journal of Chromatography A

Volumn 1385, Issue , 2015, Pages 116-123

  Delporte, Cédric ^a   Noyon, Caroline ^a   Raynal, Pierre ^b   Dufour, Damien ^a   Nève, Jean ^a   Abts, Frederic ^c   Haex, Martin ^d   Zouaoui Boudjeltia, Karim ^a   Van Antwerpen, Pierre ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Centre Hospitalier Universitaire de Charleroi   (Belgium)

^c AGILENT TECHNOLOGIES   (Belgium)

^d Agilent Technologies Inc   (Netherlands)

Author keywords

Nano LC HRMS MS; Peptide separation; Polaris chip; Proteomics

Indexed keywords

HIGH PRESSURE LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; PEPTIDES; SEPARATION; STARS;

CARDIO-VASCULAR DISEASE; CHROMATOGRAPHIC COLUMN; DETECTION AND IDENTIFICATIONS; IDENTIFICATION OF PROTEINS; LOW-ABUNDANCE PROTEINS; NANO-LC; PEPTIDE SEPARATION; POLARIS;

PROTEOMICS;

ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; ALPHA ACTININ 1; ALPHA ACTININ 4; ALPHA ENOLASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; CALGRANULIN B; CARBONATE DEHYDRATASE I; CATHEPSIN D; CERULOPLASMIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C9; FIBRONECTIN; FILAMIN A; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HAPTOGLOBIN; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN DELTA CHAIN; LUMICAN; PEROXIREDOXIN 2; TRANSGELIN; TRIOSEPHOSPHATE ISOMERASE; UNINDEXED DRUG; VIMENTIN; VINCULIN; VITRONECTIN; BIOLOGICAL MARKER; PEPTIDE; PROTEIN;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CASE REPORT; CHEMISTRY; COMPARATIVE STUDY; CONTROLLED STUDY; FLOW RATE; HUMAN; HYDROPHILICITY; LIQUID CHROMATOGRAPHY; NANOCHIP; PARTICLE SIZE; POROSITY; PRESSURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SEPARATION TECHNIQUE; TANDEM MASS SPECTROMETRY; MASS SPECTROMETRY; PROCEDURES;

BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; HUMANS; MASS SPECTROMETRY; PEPTIDES; PLAQUE, ATHEROSCLEROTIC; PROTEINS; PROTEOMICS;

EID: 84925124058     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2015.01.038     Document Type: Article

References (18)

1. Hao P., Ren Y., Pasterkamp G., Moll F.L., de Kleijn D.P., Sze S.K. Deep proteomic profiling of human carotid atherosclerotic plaques using multidimensional LC-MS/MS. Proteomics Clin. Appl. 2014, 8:631-635.
2. Mitchell P. Proteomics retrenches. Nat. Biotechnol. 2010, 28:665-670.
3. Yin H., Killeen K., Brennen R., Sobek D., Werlich M., van de Goor T. Microfluidic chip for peptide analysis with an integrated HPLC column, sample enrichment column, and nanoelectrospray tip. Anal. Chem. 2005, 77:527-533.
4. Ali I., Aboul-Enein H.Y. Role of nano liquid chromatography in pharmaceutical analyses. Curr. Pharmaceut. Anal. 2009, 5:367-380.
5. Ali I., Aboul-Enein H.Y., Cazes J. A journey from Mikhail Tswett to nano-liquid chromatography. J. Liq. Chromatogr. Relat. Technol 2010, 33:645-653.
6. Ali I., Aboul-Enein H.Y., Gupta V.K. Nano Chromatography and Capillary Electrophoresis: Pharmaceutical and Environmental Analyses 2009, Wiley & Sons, Hoboken.
7. Ali I., Aboul-Enein H.Y., Gupta V.K. Microchip-based nano chromatography and nano capillary electrophoresis in genomics and proteomics. Chromatographia 2009, 69:13-22.
8. Makinen V.P., Civelek M., Meng Q., Zhang B., Zhu J., Levian C., Huan T., Segre A.V., Ghosh S., Vivar J., Nikpay M., Stewart A.F., Nelson C.P., Willenborg C., Erdmann J., Blakenberg S., O'Donnell C.J., Marz W., Laaksonen R., Epstein S.E., Kathiresan S., Shah S.H., Hazen S.L., Reilly M.P., Lusis A.J., Samani N.J., Schunkert H., Quertermous T., McPherson R., Yang X., Assimes T.L. Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease. PLoS Genet. 2014, 10:e1004502.
9. Bleijerveld O.B., Zhang Y.N., Beldar S., Hoefer I.E., Sze S.K., Pasterkamp G., de Kleijn D.P. Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis. Proteomics Clin. Appl. 2013, 7:490-503.
10. Bergt C., Pennathur S., Fu X., Byun J., O'Brien K., McDonald T.O., Singh P., Anantharamaiah G.M., Chait A., Brunzell J., Geary R.L., Oram J.F., Heinecke J.W. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc. Natl. Acad. Sci. USA 2004, 101:13032-13037.
11. Holzer M., Gauster M., Pfeifer T., Wadsack C., Fauler G., Stiegler P., Koefeler H., Beubler E., Schuligoi R., Heinemann A., Marsche G. Protein carbamylation renders high-density lipoprotein dysfunctional. Antioxid. Redox. Signal. 2011, 14:2337-2346.
12. Delporte C., Boudjeltia K.Z., Noyon C., Furtmuller P.G., Nuyens V., Slomianny M.C., Madhoun P., Desmet J.M., Raynal P., Dufour D., Koyani C.N., Reye F., Rousseau A., Vanhaeverbeek M., Ducobu J., Michalski J.C., Neve J., Vanhamme L., Obinger C., Malle E., Van Antwerpen P. Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100. J. Lipid Res. 2014, 55:747-757.
13. Delporte C., Van Antwerpen P., Zouaoui Boudjeltia K., Noyon C., Abts F., Metral F., Vanhamme L., Reye F., Rousseau A., Vanhaeverbeek M., Ducobu J., Neve J. Optimization of apolipoprotein-B-100 sequence coverage by liquid chromatography-tandem mass spectrometry for the future study of its posttranslational modifications. Anal. Biochem. 2011, 411:129-138.
14. Ricker R.D., Woodward C.B., 3rd K., Forrer B.J., Permar W., Chen Options for rapid analysis of peptides and proteins, using wide-pore, superficially porous, high-performance liquid chromatography particles with unique bonded-phase ligands. J. Chromatogr. Sci. 2008, 46:261-268.
15. S. Buckenmaier, J., Mora, T. van de Goor, C., Miller, P. Perkins, Enhanced chromatography with the Agilent Polaris-HR-Chip-3C18 improved LC/MS/MS proteomics results, Agilent Technologies Application Notes, Technical Overview, 2012, http://insidelcms.chem.agilent.com/pdf/5991-0735en.pdf.
16. Sokolov A.V., Ageeva K.V., Pulina M.O., Cherkalina O.S., Samygina V.R., Vlasova I.I., Panasenko O.M., Zakharova E.T., Vasilyev V.B. Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other. Free Radic. Res. 2008, 42:989-998.
17. Huang Y., DiDonato J.A., Levison B.S., Schmitt D., Li L., Wu Y., Buffa J., Kim T., Gerstenecker G.S., Gu X., Kadiyala C.S., Wang Z., Culley M.K., Hazen J.E., Didonato A.J., Fu X., Berisha S.Z., Peng D., Nguyen T.T., Liang S., Chuang C.C., Cho L., Plow E.F., Fox P.L., Gogonea V., Tang W.H., Parks J.S., Fisher E.A., Smith J.D., Hazen S.L. An abundant dysfunctional apolipoprotein A1 in human atheroma. Nat. Med. 2014, 20:193-203.
18. Delporte C., Van Antwerpen P., Vanhamme L., Roumeguere T., Zouaoui Boudjeltia K. Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. Mediators Inflamm. 2013, 2013:18.